Related Experiment Videos
Neuropharmacology of emesis induced by anti-cancer therapy
Trends in Pharmacological Sciences
|September 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neural networks involved in nausea in adult humans: A systematic review.
Autonomic neuroscience : basic & clinical·2022
Farnesoid X receptor - a molecular predictor of weight loss after vertical sleeve gastrectomy?
Obesity science & practice·2019
Regionally dependent neuromuscular functions of motilin and 5-HT₄ receptors in human isolated esophageal body and gastric fundus.
Neurogastroenterology and motility·2014
Drugs acting at 5-HT4 , D2 , motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach.
Neurogastroenterology and motility·2014
The Concise Guide to PHARMACOLOGY 2013/14: overview.
British journal of pharmacology·2014
Ghrelin and motilin receptor agonists: time to introduce bias into drug design.
Neurogastroenterology and motility·2014
Targeting CH25H restores p62-mediated α-synuclein clearance.
Trends in pharmacological sciences·2026
B cells enter the synaptic conversation.
Trends in pharmacological sciences·2026
Lipophagy and lipid droplets in neurodegeneration.
Trends in pharmacological sciences·2026
Bias from within: intracellular allosterism and the ICL2 hub.
Trends in pharmacological sciences·2026
Closing AI drug-regulatory gaps through harmonized oversight.
Trends in pharmacological sciences·2026
Midnolin-directed protein degradation beyond ubiquitin.
Trends in pharmacological sciences·2026
Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.
PLoS neglected tropical diseases·2026
SRPK Inhibition in Cholangiocarcinoma Cells Induces LAMB1-Associated Adaptive Responses and Enhances Growth Suppression by the MEK Inhibitor U0126 via the LAMB1/ERK/c-JUN Axis.
Frontiers in bioscience (Landmark edition)·2026
Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial.
Journal of clinical psychopharmacology·2026